Valencia Nutrition Ltd
Valencia Nutrition Ltd is a FMCG/nutraceutical company developing, manufacturing and distributing functional beverages, nutrition products and other fortified consumer foods. It combines own PET bottling with contract manufacturing and brand/distribution. [1]
- Market Cap ₹ 118 Cr.
- Current Price ₹ 59.4
- High / Low ₹ 78.7 / 40.1
- Stock P/E
- Book Value ₹ 21.3
- Dividend Yield 0.00 %
- ROCE 2.56 %
- ROE 2.77 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 2.74% over last quarter.
Cons
- Stock is trading at 2.79 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
- Company has high debtors of 397 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|
| 8.41 | 7.78 | 8.60 | |
| Sales growth | -7.49% | -19.02% | |
| 7.55 | 7.62 | 12.94 | |
| Operating Profit | 0.86 | 0.16 | -4.34 |
| OPM % | 10.23% | 2.06% | -50.47% |
| 0.58 | 1.70 | 1.59 | |
| Interest | 0.15 | 0.13 | 0.16 |
| Depreciation | 0.21 | 0.64 | 1.20 |
| Profit before tax | 1.08 | 1.09 | -4.11 |
| Tax % | 0.00% | 0.00% | |
| 1.07 | 1.09 | -4.10 | |
| EPS in Rs | 0.63 | 0.59 | -2.05 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -239% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 46% |
| 3 Years: | 39% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|
| Equity Capital | 16.98 | 18.32 | 19.84 |
| Reserves | 19.60 | 23.87 | 22.41 |
| 1.49 | 15.13 | 18.44 | |
| 0.35 | 1.73 | 3.32 | |
| Total Liabilities | 38.42 | 59.05 | 64.01 |
| 6.04 | 15.88 | 21.64 | |
| CWIP | 0.14 | 10.67 | 8.77 |
| Investments | 2.93 | 1.75 | 0.05 |
| 29.31 | 30.75 | 33.55 | |
| Total Assets | 38.42 | 59.05 | 64.01 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -15.73 | -8.19 | |
| -10.17 | -16.79 | |
| 33.57 | 17.39 | |
| Net Cash Flow | 7.67 | -7.60 |
| Free Cash Flow | -19.81 | -28.55 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -1,829% | -5,119% |
Ratios
Consolidated / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 281.24 | 397.37 |
| Inventory Days | 216.24 | 1,577.36 |
| Days Payable | 10.57 | 154.92 |
| Cash Conversion Cycle | 486.90 | 1,819.82 |
| Working Capital Days | 739.55 | 1,270.93 |
| ROCE % | 2.56% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Equity Shares Outstanding shares ・Standalone data |
|
||||||||
| Number of Employees count ・Standalone data |
|||||||||
| Beverages Segment Revenue Share % ・Standalone data |
|||||||||
| Number of Shareholders count ・Standalone data |
|||||||||
| Number of Contract Bottling Plants count ・Standalone data |
|||||||||
| Production Volume cases ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Submission Of Half-Yearly Business Update For FY 2026-27 (As On September 30,2026)
- Half-year update details ₹1,500 crore fundraise, subsidiary restructuring, juice line commissioning, 1,98,000-case order book.
-
Disclosure Of Related Party Transactions (RPT) Pursuant To Reg. 23(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Half-Year Ended September 30, 2026.
- Half-year related party transaction disclosure filed for September 30, 2026.
-
Disclosure Of Statement Of Deviation Or Variation Pursuant To Regulation 32 Of The SEBI (LODR) Regulations, 2015 For The Half-Year Ended September 30, 2026 And Disclosure Regarding Forfeiture Of Unexercised Convertible Warrants
- Filed deviation statement for preferential warrants; ₹2.39 crore upfront consideration forfeited on 23.9 lakh unexercised warrants.
- Outcome Of Board Meeting Held On Saturday, November 14, 2026, At 11:00 A.M. Ref: Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, November 14, 2026, At 11:00 A.M.
Ref: Regulation 30 And 33 Of SEBI (LODR)
Regulations, 2015
- Board approved H1 FY2026-27 results, unmodified audit review, and forfeited 23.90 lakh warrants worth ₹2.39 crore.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
Business Overview:
Founded in 2013, VNL began with VitaMe/Bounce; VitaMe was withdrawn and the business restructured from 2021. The operating core is PET beverages through the Hyderabad subsidiary plus aluminium-can beverages, with snacks/biscuits and lifecycle nutrition newer.[1]